Kellogg recalls some Special K cereal, citing glass fragments
NEW YORK (Reuters) - Kellogg Co said 36,000 packages of its Special K Red Berries cereal could contain dangerous glass fragments and have been pulled from the market, the latest...
Home > Reviews
All Stories
Sanofi boosting stake in Regeneron
(Reuters) - French drugmaker Sanofi SA is buying more shares in U.S. biotech company Regeneron Pharmaceuticals Inc , its partner in the development of potential blockbuster treatments for cholesterol and...
Pfizer fourth-quarter results top forecast, gives cautious 2013 view
(Reuters) - Pfizer Inc on Tuesday reported better-than-expected fourth-quarter results, helped by rebounding sales in emerging markets, but the drugmaker forecast that 2013 profits would be weaker than Wall Street...
Abbott results bode well for spun-off AbbVie
(Reuters) - AbbVie Inc , the new branded pharmaceuticals company spun off by Abbott Laboratories Inc , is off to a good start, judging by fourth-quarter sales of arthritis drug...
J&J mulls sale of diagnostics unit
(Reuters) - Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when it reported quarterly earnings. The diversified healthcare company...
Analysis: Alimta patent seen as Lilly’s “wild card”
NEW YORK (Reuters) - Eli Lilly & Co may have a $15 billion wild card up its sleeve as it waits for desperately needed new drugs to bear fruit. Should...
Merck cholesterol drug fails; risks seen
(Reuters) - A major trial of Merck & Co Inc's Tredaptive medicine to increase "good" HDL cholesterol has raised safety concerns and showed it was no better at preventing heart...
Merck cholesterol drug fails; risks seen
(Reuters) - A major trial of Merck & Co Inc's Tredaptive medicine to increase "good" HDL cholesterol has raised safety concerns and showed it was no better at preventing heart...
Lilly likens Alzheimer’s race to 1920s insulin quest
(Reuters) - Drugmaker Eli Lilly & Co is confident it will do for Alzheimer's patients what it did almost a century ago for diabetics - find a breakthrough treatment, even...
Lilly likens Alzheimer’s race to 1920s insulin quest
(Reuters) - Drugmaker Eli Lilly & Co is confident it will do for Alzheimer's patients what it did almost a century ago for diabetics - find a breakthrough treatment, even...